Calcium Chloride Patents (Class 424/678)
  • Patent number: 6986905
    Abstract: The present invention relates to a pharmaceutical composition and the method for the preparation thereof, The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, calcium chloride, calcium gluconate, and the like, and 3˜18% (w/v) of one or more substances selected from hydroxyethylstarch, dextran, carboxymethylstarch, polyvinyl-pyrrolidone, gelatin derivatives, and the like as well as the remainder of conventional injections, as long as sodium chloride is not less than 1.5% (w/v). The pharmaceutical composition of the present invention is used to treat and save the wounded and patients, as well as to treat shock, its advantages include safe and convenient use, rapid and good curative effect, long time maintenance, extensive uses and the like.
    Type: Grant
    Filed: November 15, 2000
    Date of Patent: January 17, 2006
    Inventor: Chaoying Zhao
  • Patent number: 6932966
    Abstract: A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatment mixture preferably additionally includes sodium benzoate to act as a preservative. A method of producing a skin treatment mixture includes the steps of providing a quantity of purified water; adding a quantity of sea salt to the quantity of purified water; boiling the purified water and sea salt; cooling the purified water and sea salt; adding a quantity of lysozyme to the purified water and sea salt; sterilizing the mixture and testing it for bacteria. A method of treating a pierced skin area includes the step of applying to the pierced area a reconstituted ocean water mixture of sea salt and lysozyme.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: August 23, 2005
    Inventor: Edward Kolos
  • Patent number: 6923987
    Abstract: A solid preparation for dialysis for preparing a double preparation type sodium bicarbonate solid preparation for dialysis in which there is no fear that a sugar component is decomposed or colored, and which can maintain stability and is also excellent in content homogeneity and a process for producing the same. The solid preparation for dialysis is a mixture of a first composition composed of core particles including sodium chloride and a coating layer containing one or more electrolytes, a second composition composed of core particles including a sugar that is covered with a coating layer comprising the same sugar or a different sugar, and an acid.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: August 2, 2005
    Assignee: Nipro Corporation
    Inventors: Toshiya Kai, Kazuyuki Yamamoto, Kazutaka Fujiki, Makoto Sato
  • Patent number: 6908628
    Abstract: Wide spectrum disinfecting and antiseptic composition for use in the fields of human medicine, veterinary science and industry, characterized because it includes: Hydrogen peroxide, lactic acid and halogen salts (Br, I) and/or salts of heavy metals (for example, silver halides) with surfactant agents, either cationic, like chlorhexidine and/or quaternary ammonium salts, like didecyl-methyl-polyoxy-ethyl-ammonium propionate, chlorides of ammonium or compounds of ammonium propylamide or anionic, like lauryl sulphate, dodecyl sulphate or alkyl succinic salts, with suitable excipients, some of which may be ethyl or isopropyl alcohol, chlorhexidine, non-chlorinated quaternary ammonium salts, like didecyl-methyl-polyoxy-ethyl-ammonium propionate, combined or not with iodine, and/or its salts, together with excipients, some of which may be ethyl or isopropyl alcohol.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: June 21, 2005
    Assignee: OFTRAI, S.L.
    Inventor: Rafael Herruzo Cabrera
  • Patent number: 6884441
    Abstract: In contrast to the prior art, the essential components of dialyzing liquids are not provided as a dry concentrate or as a genuine solution at the place of dialysis, but as a suspension of undissolved or incompletely dissolved substances, preferably sodium chloride, optionally sodium acetate, in a solution of the remaining components. The suspension is prepared, stored, transported and used in a form designated as an acid cartridge or acetate cartridge, respectively. At the place of dialysis a liquid dialysis concentrate is prepared from the suspension by means of an apparatus, which is here suggested, and can be processed into dialyzing liquid with the existing dosing and safety systems of commercially available dialyzers. The prestage of a dialysis concentrate, which is described in this invention as a suspension, constitutes the supply form with the highest substance density for the components of acid and acetate-containing dialyzing liquids.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: April 26, 2005
    Assignee: Haas Medizintechnik GmbH
    Inventors: Manfred Pippert, Uwe Hildmann, Hans-Gunther Eigendorf
  • Patent number: 6881424
    Abstract: A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a strong oxyacid, wherein the resultant acidic composition is less corrosive to a ferrous metal than a solution of a mineral acid having the same acidic pH value as that of the acidic composition, and where in the acid composition is more biocidal than a mixture of the organic acid and a metal salt of the organic acid which mixture has the same acid normality value as that of the acidic composition. The acidic composition can be prepared by mixing at least one regenerating acid, at least one metal base, and at least one organic acid, wherein the amount of the regenerating acid is in excess of the equivalent amount of the metal base.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: April 19, 2005
    Assignee: Mionix Corporation
    Inventors: Maurice Clarence Kemp, Robert Blaine Lalum, David E. Lewis, Robert H. Carpenter
  • Patent number: 6841172
    Abstract: The invention relates to methods and compositions for delivering iron to an iron-deficient patient, more particularly, to methods whereby an iron complex comprising divalent or trivalent ionic iron complexed with one or more low molecular weight anions is administered to a patient by transfer from dialysate. A complex selected according to the invention is non-polymeric; soluble in an aqueous medium; chemically stable, thereby preventing the dissociation of iron ions from the anions under conditions according to the invention; and can be well absorbed into blood and the living body. Also provided are dialysate compositions including therein an iron complex selected according to the invention, and dialysate concentrates which may be diluted to yield an inventive dialysate composition.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: January 11, 2005
    Assignee: HemoCleanse, Inc.
    Inventor: Stephen R. Ash
  • Patent number: 6830764
    Abstract: Application of an alkaline earth metal salt selected from calcium and strontium salts can steadily denature the allergens those exist in the environment without any coloring trouble on the treated material.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: December 14, 2004
    Assignees: Shinto Fine Co., Ltd., Sumitomo Chemical Co., Ltd.
    Inventors: Keiichiro Inui, Mariko Mikame
  • Patent number: 6814984
    Abstract: The present invention is directed to frozen biocidal compositions. Specifically, the biocidal compositions comprise a frozen aqueous solution of a plurality of ions selected from the group consisting of halide and oxyhalide ions. The frozen biocidal compositions are useful in preserving or extending the shelf-life of perishable articles.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: November 9, 2004
    Assignee: Clean Water International LLC
    Inventors: David C. Rose, Lawrence J. Ventura
  • Patent number: 6797260
    Abstract: A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin” (epithelial) tissues. The composition is preferably in the form of a paste which promotes ease of application and use of the composition. A variety of instruments can be used in application and cleanup of the composition showing versatile unparalleled friendly usage. The composition preferably comprises aluminum chloride, ferric sulfate (subsulfate), regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and a solvent. The composition has many dental and medical procedure applications.
    Type: Grant
    Filed: September 18, 2003
    Date of Patent: September 28, 2004
    Inventor: Terence Prevendar
  • Publication number: 20040151781
    Abstract: Pharmaceutical formulation, its use, and method for its manufacture The present invention relates to a pharmaceutical formulation of a calcium salt and a dry plant extract in the form of a coated tablet, wherein it has a core of at least one dry plant extract, enveloped by at least one coating of at least one calcium salt. The plant extracts for the core may be selected from: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard lily); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (purple trefoil); Oenothera biennis hom. (primrose); Glycine soja (soy bean); Serenoa repens (saw-palmetto); Urtica dioica (stinging nettle), in particular its root; Cucurbita pepo (pumpkin), in particular its seed; Pygeum africanum; as well as suitable mixtures of these.
    Type: Application
    Filed: December 8, 2003
    Publication date: August 5, 2004
    Inventor: Michael A Popp
  • Patent number: 6737083
    Abstract: A reconstituted ocean mixture comprising, sea salt, and the purified product of reverse osmosis of water. A method is provided for treating a pierced area of a person's skin comprising applying to the pierced area a reconstituted ocean water mixture of sea salt and the product of reverse osmosis of water.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: May 18, 2004
    Inventors: Edward Kolos, Jeffrey D. Newsom
  • Patent number: 6723334
    Abstract: This invention provides orthopedic cement compositions, containing calcium phosphate component, an anion-donating accelerator to promote rapid setting, and a calcium aluminate component. Further provided are methods for orthopedic repair, including placing the cement at said surgical site by applying low shearing force to said cement to initiate flow.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: April 20, 2004
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Thomas D. McGee, Marie L. Roemhildt
  • Patent number: 6716884
    Abstract: A pharmaceutical composition for the administration of phloroglucinol includes phloroglucinol in combination with a buffer system capable of buffering the composition when placed in an aqueous medium to a pH between 3 and 7.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: April 6, 2004
    Assignee: Promindus (Actions Promotionnelles Dans l'Industrie et le Commerce)
    Inventors: Abderrahim Bennis, Jean-Jacques Serrano, Farid Bennis
  • Patent number: 6709680
    Abstract: The invention concerns the use of iso-osmotic saline solutions, in particular obtained from sea water, to obtain a medicine for cerumenolytic treatment.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: March 23, 2004
    Assignee: Laboratories Goemar S.A.
    Inventors: Jean-Claude Yvin, Isabelle Cadulal, Olivier Tabary
  • Patent number: 6689393
    Abstract: A solution, in particular for hemodialysis or peritoneal dialysis that permits attaining a desired glucose concentration without affecting the concentrations of other components in the solution. The solution consists of at least three individual solutions that are combined and administered after heat sterilization. The first solution contains calcium ions, electrolyte salts and optionally glucose in a concentration of 0-1000 mM and is acidified to a pH of less than 4.0 with a physiologically tolerable acid. The second solution contains glucose in a concentration different from that of the first solution and the remaining components of the first solution in the same concentration. The third solution contains a buffer in the physiological range. Also provided is a method of preparing a solution according to the invention, where the desired mixing ratio of the separate solutions is automatically established by a dialysis machine or peritoneal dialysis cycler.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: February 10, 2004
    Assignee: Fresenius Medical Care Deutschland
    Inventor: Thomas Knerr
  • Patent number: 6689392
    Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: February 10, 2004
    Assignee: Agricare Ltd.
    Inventor: Ran Lifshitz
  • Patent number: 6682762
    Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: January 27, 2004
    Assignee: Heart-O-Dixie Animal Nutrition, LLC
    Inventor: Martin Kenneth Register
  • Publication number: 20040013730
    Abstract: The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well as the prevention and treatment of sexually transmitted diseases and vaginal infections through the application of the device.
    Type: Application
    Filed: July 31, 2003
    Publication date: January 22, 2004
    Inventors: Brij B. Saxena, Mukul Singh, Sidney Lerner
  • Patent number: 6663902
    Abstract: The present invention relates to a biocidal composition, designed for the generation of chlorine dioxide, comprising at least one iodo-compound having at least one iodine atom and a source of chlorite ions. The molar ration of chlorite ions to iodine atoms is 2 or greater. The composition finds use in a variety of applications including methods of cleaning, sanitizing, deodorizing, and disinfecting various surfaces.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: December 16, 2003
    Assignee: Ecolab Inc.
    Inventors: Robert D. P. Hei, David Daniel McSherry, Kim R. Smith, Keith E. Olson
  • Patent number: 6627229
    Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.
    Type: Grant
    Filed: June 23, 2001
    Date of Patent: September 30, 2003
    Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
  • Publication number: 20030158097
    Abstract: Novel medicinal compositions aiming at delivering a medicine to a specific site of the large intestine; and preparations for intestinal administration with the use of the same. Namely, medicinal compositions, whereby a medicine can be delivered to a specific site of the large intestine, characterized by containing a P-glycoprotein modifier; and preparations for intestinal administration with the use of the same.
    Type: Application
    Filed: November 21, 2002
    Publication date: August 21, 2003
    Inventors: Norifumi Tanida, Takeshi Goto, Yuji Kurosaki
  • Patent number: 6607716
    Abstract: The invention discloses a natural treatment for ecto-parasitic infestation, particularly effective against lice be it head, body or pubic. A preferred gel composition includes a salt, a plant essence, and a pharmaceutically acceptable gelling agent. Besides gel, the composition designed for use on scalp hair may be formulated as a shampoo, a detangling spray conditioner, mousse, hair spray, or hair styling emulsion. The composition may be formulated as an ointment or lotion for topical use in areas with sparse hair. The invention also discloses a method of use of the composition, which is especially suited for treatment of the hair of infested children. The composition and method benefit from the soothing effects of aroma therapy. An additional benefit is that ecto-parasites do not develop resistance to the composition, which may be used repeatedly with no ill effects to the host.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: August 19, 2003
    Assignee: Tech Labs, Inc.
    Inventors: Robert Lee Smith, Steven Dale Smith, Wendy Dennis Langley, John Mark Christensen
  • Publication number: 20030118670
    Abstract: Provided are compositions and methods for prevention or mitigation of allergic reactions in humans and animals. Novel compositions comprised of, e.g., an acidic salt solution of aluminum, calcium or magnesium, are provided for topical or contact application to physically and/or chemically alter an allergenic protein present in the environment and thereby lower the allergenicity of the protein. The compositions of the invention, e.g., comprised of aluminum sulfate, can be used to deactivate many types of proteinaceous allergens such as dust mite and cockroach body dust, animal dander, dried saliva, mold spore antigens, airborne pollen protein and the like. Compositions can be applied on an as needed basis to a wide variety of surfaces, e.g., floor coverings, walls bedding, window coverings, vehicle (e.g., automobile) interiors, furniture, pet bedding, plants (e.g., household plants) and the like. The compositions provided may also be utilized to mitigate allergens present on clothing, e.g.
    Type: Application
    Filed: July 11, 2002
    Publication date: June 26, 2003
    Inventor: C. Steven Smith
  • Patent number: 6565891
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: May 20, 2003
    Assignee: Tsar Health Private Ltd.
    Inventor: Ranjit Kumar Chandra
  • Patent number: 6562378
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: May 13, 2003
    Assignee: TSAR Health Private Ltd.
    Inventor: Renjit Kumar Chandra
  • Patent number: 6558711
    Abstract: A method for promoting colon health in a subject comprising administering a dose of calcium to the subject that is effective to reduce carcinogenesis. Particularly provided is a method for reducing the risk of recurrence of colorectal adenomas, comprising administering a dose of calcium carbonate effective to promote colon health. In an example, 1200 mg of elemental calcium (supplied in 3000 mg of calcium carbonate) administered once or twice daily resulted in decreased risk of recurrent colorectal adenomas in patients with a history of colorectal adenomas.
    Type: Grant
    Filed: August 1, 2002
    Date of Patent: May 6, 2003
    Assignee: The Trustees of Dartmouth College
    Inventor: John A. Baron
  • Publication number: 20030068359
    Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.
    Type: Application
    Filed: October 9, 2001
    Publication date: April 10, 2003
    Inventor: Martin Kenneth Register
  • Publication number: 20020182239
    Abstract: This invention provides a composition comprising formalin and chloride. In another aspect of the invention, the composition may also comprise magnesium chloride, calcium chloride, or lanthanum chloride. This invention provides a composition comprising formalin and lanthanum chloride. This invention provides an ointment which comprises a composition comprising formalin and chloride. This invention provides a method of inhibiting nematocyst or polar capsule discharge and a method of protecting a subject from a sting from an organism discharging nematocyst or polar capsule discharge comprising applying an effective amount of the composition of comprising formalin and chloride, to the skin of a subject prior to contact with nematocysts or polar capsules, thereby inhibiting nematocyst or polar capsule discharge.
    Type: Application
    Filed: May 29, 2002
    Publication date: December 5, 2002
    Inventor: Amit Lotan
  • Patent number: 6488966
    Abstract: A method for reducing a risk of carcinogenesis in a subject comprising administering a dose of calcium to the subject that is effective to reduce carcinogenesis. Particularly provided is a method for reducing the risk of recurrence of colorectal adenomas, comprising administering a dose of calcium carbonate effective to reduce the risk of colorectal adenomas. In an example, 1200 mg of elemental calcium (supplied in 3000 mg of calcium carbonate) administered twice daily resulted in decreased risk of recurrent colorectal adenomas in patients with a history of colorectal adenomas.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: December 3, 2002
    Assignee: The Trustees of Dartmouth College
    Inventor: John A. Baron
  • Patent number: 6475529
    Abstract: The present invention provides devices and methods for stabilizing bicarbonate-based solutions for peritoneal dialysis or hemofiltration. The bicarbonate-based solutions of the present invention are formulated and stored in at least two parts—an alkaline bicarbonate concentrate and an acidic concentrate. The alkaline bicarbonate concentrate is adjusted to have a pH of about 8.6 to 10.0. The acidic concentrate is adjusted to have a stable, acidic pH ranging from about 1.0 to 3.0. Upon mixing, although some variation in the pH of the mixed bicarbonate solution exists, the inventors have discovered that with the appropriate selection of the parameters of the concentrates, the pH of the mixed solution is always within an acceptable physiological range.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: November 5, 2002
    Assignee: Baxter International Inc.
    Inventors: Annick Duponchelle, Dirk Faict, Patrick Balteau, Jean-Pierre Hartman, Leo Martis, Francesco Peluso
  • Publication number: 20020136770
    Abstract: A method of delivering active material using microbeads comprising droplets of active material entrained in a hydrophilic matrix. Compositions comprising the microbeads may be sprayable. The microbeads of the invention may be controllable by exposing the microbeads to high or low humidity or moisture.
    Type: Application
    Filed: October 22, 1999
    Publication date: September 26, 2002
    Inventor: DOUGLAS QUONG
  • Patent number: 6451352
    Abstract: The invention concerns the use of iso-osmotic saline solutions in particular obtained from sea water, to obtain a medicine designed for a treatment preventing and limiting the release of chemical mediators responsible for causing inflammatory phenomena in the human respiratory tracts.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: September 17, 2002
    Assignee: Laboratoires Goemar S.A.
    Inventors: Jean-Claude Yvin, Olivier Tabary, Jacky Jacquot, Edith Puchelle
  • Patent number: 6447809
    Abstract: A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: September 10, 2002
    Assignee: Metagenics, Inc.
    Inventors: Kim C. Krumhar, Holly A. Johnson
  • Patent number: 6413551
    Abstract: A termiticide which comprises at least one compound which in the presence of a termite produces a termiticidally effective amount of hydrogen sulfide.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: July 2, 2002
    Inventor: David William Holloway
  • Patent number: 6395311
    Abstract: The present invention provides a novel vehicle for the delivery of biologically active agents. The vehicle, Maxcell™, is formulated from a novel combination of natural plant extracts and is comprised of Aloe vera polysaccharide fraction Immuno-10, cAMP, piperine, calcium phosphate and glycyrrhizinic acid.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: May 28, 2002
    Assignee: Univera Pharmaceuticals, Inc.
    Inventor: Qi Jia
  • Publication number: 20020061340
    Abstract: Self-preserved nasal, inhalable and topical ophthalmic preparations and medications which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications. The nasal, inhalable, and topical ophthalmic preparations and medications are mildly buffered and maintain a stable pH at pH 3.5 or lower.
    Type: Application
    Filed: September 20, 2001
    Publication date: May 23, 2002
    Inventor: Lee Shahinian
  • Publication number: 20020061334
    Abstract: A solid preparation for dialysis for preparing a double preparation type sodium bicarbonate solid preparation for dialysis in which there is no fear that a sugar is decomposed or colored, and which can maintain stability and also is excellent in content homogeneity and a process for producing the same. The solid preparation for dialysis is a mixture of a first composition composed of core particles including sodium chloride that are coated with a coating layer containing one or more electrolytes, a second composition composed of core particles including a sugar that are covered with a coating layer containing one or more electrolytes, and an acid.
    Type: Application
    Filed: September 27, 2001
    Publication date: May 23, 2002
    Inventors: Toshiya Kai, Kazuyuki Yamamoto, Kazutaka Fujiki, Makoto Sato
  • Patent number: 6387412
    Abstract: A storage stable magnesium oxychloride coated granular animal feed mineral supplement composition resistant to disintegration cause by moisture absorption and attrition, comprising granular mineral nutrients useful as animal feed supplements and magnesium oxychloride coatings amounting to between 0.5 and 10.0 percent of the weight of the granules, formed on the granules of mineral nutrients by coreaction of magnesium chloride and magnesium oxide. An additional coating of between 0.2 and 2.0 percent magnesium stearate formed on the magnesium oxychloride may be used to decrease the rate of wetting of the granular animal feed mineral supplements.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: May 14, 2002
    Assignee: Agri-Nutrients Technology Group, Inc.
    Inventor: William P. Moore
  • Publication number: 20020009474
    Abstract: This invention relates to a hydrophilic matrix containing a pharmaceutically acceptable calcium source for use as a calcium supplement for mammals.
    Type: Application
    Filed: April 6, 1999
    Publication date: January 24, 2002
    Inventors: PRASAD S. ADUSUMILLI, KENNETH G. MANDEL, HARESH L. MIRCHANDANI
  • Patent number: 6338837
    Abstract: Compositions for inhibiting nematocyst or polar capsule discharge are provided in the form of an effective amount of antihistamine, an effective amount of antihistamine and an effective amount of at least one cation, or an effective amount of at least one cation. The compositions can be in the form of ointments or can be added to the environment surrounding the nematocysts or polar capsules. Methods of inhibiting nematocyst or polar capsule discharge using the compositions of the invention are also provided.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: January 15, 2002
    Assignee: Nidaria Technology Ltd.
    Inventor: Amit Lotan
  • Patent number: 6331540
    Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug, xanthan gum and a water-soluble calcium salt in an amount sufficient to make the fluoroquinolone antibiotic drug and xanthan gum compatible are disclosed.
    Type: Grant
    Filed: October 10, 2000
    Date of Patent: December 18, 2001
    Assignee: Alcon Universal Ltd.
    Inventor: Bhagwati P. Kabra
  • Publication number: 20010051184
    Abstract: The compound curcumin, derived from turmeric, inhibits phosphorylase kinase and, by doing so, exhibits a number of physiological effects related to the control of inflammation and cellular proliferation. However, curcumin is effective only when in solution. Curcumin is almost completely insoluble in water or in oils, but is soluble in alcohols. Accordingly, a method for treating inflammation in a mammal comprising administering curcumin in a solution containing at least one alcohol to a mammal to detectably inhibit the activity of phosphorylase kinase in the blood of the mammal or in a tissue of the mammal. The alcohol is preferably ethanol, 1-propanol, or 2-propanol; most preferably, it is ethanol. Instead of curcumin, a curcumin derivative or curcuminoid can be administered.
    Type: Application
    Filed: May 20, 1999
    Publication date: December 13, 2001
    Inventor: MADALENE C.Y. HENG
  • Patent number: 6322821
    Abstract: A composition for preventing and treating milk fever in freshening cows, and a method of administering the composition. The basic composition is a mixture of water, calcium chloride, propylene glycol, B vitamins and minerals. The calcium content is lower than conventional calcium treatments used for this purpose. The propylene glycol gives the cow an energy boost and sweetens the taste so the cow does not object to it as it does to conventional gels and liquids. The B vitamins stimulate the cow's appetite. The minerals replace minerals lost in the milk and also help the cow absorb calcium. The composition of the present invention is in a liquid form and is preferably administered using a 200-300 cc drench gun. The end of the dispensing tube of the drench gun is placed between the teeth and cheek of the cow near the receptors that stimulate the esophageal groove reflex.
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: November 27, 2001
    Inventor: Jack W. Register
  • Patent number: 6309673
    Abstract: The present invention provides devices and methods for stabilizing bicarbonate-based solutions for peritoneal dialysis or hemofiltration. The bicarbonate-based solutions of the present invention are formulated and stored in at least two parts—an alkaline bicarbonate concentrate and an acidic concentrate. The alkaline bicarbonate concentrate is adjusted to have a pH of about 8.6 to 10.0. The acidic concentrate is adjusted to have a stable, acidic pH ranging from about 1.0 to 3.0. Upon mixing, although some variation in the pH of the mixed bicarbonate solution exists, the inventors have discovered that with the appropriate selection of the parameters of the concentrates, the pH of the mixed solution is always within an acceptable physiological range.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: October 30, 2001
    Assignee: Baxter International Inc.
    Inventors: Annick Duponchelle, Dirk Faict, Patrick Balteau, Jean-Pierre Hartman, Leo Martis, Francesco Peluso
  • Patent number: 6294570
    Abstract: Aqueous endosulfan microcapsule dispersions in which the dispersed microcapsules comprise endosulfan, an organic solvent or solvent mixture and a capsule-forming material based on isocyanate prepolymers and the aqueous phase which represents the dispersion medium comprises surfactants, a water-soluble inorganic salt with or without other formulation aids, which include a relatively small amount of capsule-forming material, and a process for their preparation.
    Type: Grant
    Filed: March 9, 1999
    Date of Patent: September 25, 2001
    Assignee: Aventis CropScience GmbH
    Inventors: Hans-Peter Krause, Thomas Maier, Jan Nicolaas Bremmer
  • Patent number: 6287548
    Abstract: The present invention provides a composition of matter which has been demonstrated to be a very effective treatment for acne, seborrheic dermatitis and related skin diseases when applied to and contacted with affected skin areas, while avoiding the disadvantages and complications attendant to more established treatments. The composition comprises a synthetic mixture of salts which, when dissolved in a solvent such as water, is ionically composed primarily of a mixture of sodium and magnesium cations and chloride and sulfate anions, and which is preferably free of added zinc. More specifically, the salt mixture according to the present invention comprises the following range of composition in grams/kilogram of salt mixture in the ionic state, the balance being water of hydration: I.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: September 11, 2001
    Assignee: Bio.Life International AG
    Inventor: Hans F. Biener
  • Patent number: 6271216
    Abstract: A stable physiologic balanced salt solution of a hyaluronate salt, such as sodium hyaluronate, is provided which contains calcium ion, for example, in the form of calcium chloride or calcium acetate, and magnesium ion, for example in the form of magnesium chloride or magnesium acetate, together with sodium chloride, potassium chloride or potassium acetate, sodium acetate, sodium citrate and water, and optionally bicarbonate, dextrose and glutathione disulfide, preservatives and other conventional ingredients employed in irrigating solutions. This solution is used as a visco-elastic ophthalmic device during ophthalmic surgery.
    Type: Grant
    Filed: July 9, 1992
    Date of Patent: August 7, 2001
    Assignee: Allergan
    Inventors: Robert J. Mello, William P. Tew, Narlin B. Beaty
  • Publication number: 20010007868
    Abstract: Methods and compositions of matter are provided that enable a phased reduction of body iron stores to near a iron deficiency level, and thereafter maintain the body iron stores at that level by reducing further iron accumulation. In a first phase, a patient's body iron stores are reduced to a level of near iron deficiency by regular periodic phlebotomy or use of pharmacological agents, such as iron chelators, for example, over a period of six to twelve months. In a second phase, ingested iron absorption is controlled using an oral dose, taken at mealtimes, of any of various compounds that inhibit intestinal iron absorption, or by continuing, less frequent phlebotomy.
    Type: Application
    Filed: June 4, 1999
    Publication date: July 12, 2001
    Inventor: FRANCESCO FACCHINI
  • Patent number: RE38604
    Abstract: Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: September 28, 2004
    Assignee: BTG International Limited
    Inventor: Richard L. Veech